三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
吉卡昔替尼乳膏临床试验情况(截至2025.05.29)
吉卡昔替尼乳膏临床试验情况(截至2025.05.29)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:178KB
图片尺寸:1749*642
同报告图片
/
4
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
所属报告:
泽璟制药(688266)-A股公司研究报告:兼具销售放量和研发成果兑现的优秀创新药企-250731(20页).pdf
打包全文图表
相关数据
2020-2024年CNS临床试验启动数量(按适应症划分)
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
收藏
行业数据
2026-07-14
原图定位
查看详情
全球I-III期临床试验启动数量(2016-2025年)
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
收藏
行业数据
2026-07-02
原图定位
查看详情
图表9截至2026年5月国内外脑机接口临床试验统计
PHRhYmxlPgogICAgPHRoZWFkPgogICAgICAgIDx0cj4KICAgICAgICAgICAgYGBgaHRtbAo8dGg+5YWs5Y+4L+mhueebrjwvdGg+CiAgICAgICAgICAgIDx0aD7ntK/orqHmpI3lhaXkvovmlbA8L3RoPgogICAgICAgICAgICA8dGg+5YWz6ZSu5pe26Ze06IqC54K5PC90aD4KICAgICAgICAgICAgPHRoPuS4tOW6iueJueeCuTwvdGg+CiAgICAgICAgPC90cj4KICAgIDwvdGhlYWQ+CiAgICA8dGJvZHk+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+TmV1cmFsaW5rPC90ZD4KICAgICAgICAgICAgPHRkPue6pjIw5L6LPC90ZD4KICAgICAgICAgICAgPHRkPuaIquiHszIwMjblubTliJ08L3RkPgogICAgICAgICAgICA8dGQ+57Sv6K6h5L2/55So6LaFMS415LiH5bCP5pe2PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPuWNmuedv+W6t05FTzwvdGQ+CiAgICAgICAgICAgIDx0ZD4zMuS+i++8iOazqOWGjOS4tOW6iuivlemqjO+8iTwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI15bm05bqV5a6M5oiQ5rOo5YaM5Li05bqK77yMMjAyNuW5tDPmnIjojrfmibnkuInnsbvor4E8L3RkPgogICAgICAgICAgICA8dGQ+5YWo55CD6aaW5qy+5qSN5YWl5byP5LiJ57G76K+B77yMMTAwJeS4tOW6iue7iOeCuei+vuagh++8jOe0r+iuoeWuieWFqOakjeWFpei/kTUwMDDlpKk8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+6ISR6JmO56eR5oqAPC90ZD4KICAgICAgICAgICAgPHRkPui2hTUw5L6L77yI5LulSUlU5Li65Li777yJPC90ZD4KICAgICAgICAgICAgPHRkPuaIquiHszIwMjblubQz5pyIPC90ZD4KICAgICAgICAgICAgPHRkPjUw5L2Z5L6L5o6i57Si5oCn5Li05bqK6K+V6aqM77yM5Y2z5bCG5o6o6L+b5aSa5Lit5b+D5rOo5YaM5Li05bqKPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPumYtuair+WMu+eWlzwvdGQ+CiAgICAgICAgICAgIDx0ZD7otoU1MOS+i0lJVCArIDPkvotGSU08L3RkPgogICAgICAgICAgICA8dGQ+MjAyNeW5tDPmnIjlrozmiJDlm73lhoXpppbkvotGSU08L3RkPgogICAgICAgICAgICA8dGQ+5YWo55CD5pyA5aSn5p+U5oCn55S15p6B5Lq65L2T5Y2V57uG6IOe5pWw5o2u6ZuG77yb6K6h5YiSMjAyNuW5tOW6leS4tOW6iuaAu+S+i+aVsOaOpei/keaIluWPjei2hU5ldXJhbGluazwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7igJzljJfohJHkuIDlj7figJ08L3RkPgogICAgICAgICAgICA8dGQ+MjDkvos8L3RkPgogICAgICAgICAgICA8dGQ+5oiq6IezMjAyNuW5tDXmnIg8L3RkPgogICAgICAgICAgICA8dGQ+5Y2K5L615YWl5byP56Gs6Iac5aSW5qSN5YWl77yM57O757uf57Sv6K6h5a6J5YWo5bel5L2c6LaFNjAwMDDlsI/ml7Y8L3RkPgogICAgICAgIDwvdHI+CiAgICA8L3Rib2R5Pgo8L3RhYmxlPgoK6LWE5paZ5p2l5rqQ77ya5ZCE5YWs5Y+45Y+K6aG555uu5YWs5byA5oqr6Zyy5L+h5oGv44CB5Lit5Zu96K+B5Yi45oql44CB5LiK5rW36K+B5Yi45oql44CB5paw5Y2O56S+5Lya57uP5rWO5Y+C6ICD5oql44CB5r6O5rmD5paw6Ze744CB5Lit5oqV5Lqn5Lia56CU56m26ZmiCmBgYA==
收藏
行业数据
2026-06-15
原图定位
查看详情
Lpa(a)部分管线临床数据整理(注:临床试验预计完成时间以最终公告结果为准)
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
收藏
行业数据
2026-05-28
原图定位
查看详情
全球各年度生物药临床试验启动数量
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
收藏
行业数据
2026-05-25
原图定位
查看详情
2025年中国临床试验各类型占比
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
收藏
行业数据
2026-04-27
原图定位
查看详情
2025年中国临床试验热门靶点竞争格局
IyMjIOaVsOaNruihqOagvAoKfCDpnbbngrnlkI3np7AgICAgICAgfCDnmbvorrDmlbDph4/vvIhY6L2077yJIHwg5ZCM5q+U5aKe6ZW/546H77yIWei9tO+8iSB8IOexu+WIqyAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCBNUiAgICAgICAgICAgICB8IDY4ICAgICAgICAgICAgICAgfCAyMDAlICAgICAgICAgICAgICAgfCDpq5jmvZzmlrDplJAgfAp8IFBELUwxICAgICAgICAgIHwgNjUgICAgICAgICAgICAgICB8IDExMCUgICAgICAgICAgICAgICB8IOmrmOa9nOaWsOmUkCB8CnwgQ0QzICAgICAgICAgICAgfCA2NSAgICAgICAgICAgICAgIHwgODAlICAgICAgICAgICAgICAgIHwg6auY5r2c5paw6ZSQIHwKfCBHSVBSICAgICAgICAgICB8IDU1ICAgICAgICAgICAgICAgfCA2MCUgICAgICAgICAgICAgICAgfCDpq5jmvZzmlrDplJAgfAp8IFBELTEgICAgICAgICAgIHwgNzggICAgICAgICAgICAgICB8IDcwJSAgICAgICAgICAgICAgICB8IOmrmOa9nOaWsOmUkCB8CnwgR0NDUiAgICAgICAgICAgfCA3OSAgICAgICAgICAgICAgIHwgNDAlICAgICAgICAgICAgICAgIHwg6auY5r2c5paw6ZSQIHwKfCBEUkQyICAgICAgICAgICB8IDc3ICAgICAgICAgICAgICAgfCAwJSAgICAgICAgICAgICAgICAgfCDpq5jmvZzmlrDplJAgfAp8IEhFUjIgICAgICAgICAgIHwgNTggICAgICAgICAgICAgICB8IDAlICAgICAgICAgICAgICAgICB8IOS9jui/t+ihsOmAgCB8CnwgNS1IVDJBICAgICAgICAgfCA2MiAgICAgICAgICAgICAgIHwgLTMwJSAgICAgICAgICAgICAgIHwg5L2O6L+36KGw6YCAIHwKfCBWR1NDICAgICAgICAgICB8IDYzICAgICAgICAgICAgICAgfCAtMzUlICAgICAgICAgICAgICAgfCDkvY7ov7foobDpgIAgfAp8IEhNR0NSICAgICAgICAgIHwgNjEgICAgICAgICAgICAgICB8IC00MCUgICAgICAgICAgICAgICB8IOS9jui/t+ihsOmAgCB8CnwgQ2FsY2l1bSBjaGFubmVsfCA3OCAgICAgICAgICAgICAgIHwgLTQwJSAgICAgICAgICAgICAgIHwg5L2O6L+36KGw6YCAIHwKfCBBR1QgICAgICAgICAgICB8IDgzICAgICAgICAgICAgICAgfCAtNTAlICAgICAgICAgICAgICAgfCDkvY7ov7foobDpgIAgfAp8IEFUUDRBICAgICAgICAgIHwgODggICAgICAgICAgICAgICB8IC00MCUgICAgICAgICAgICAgICB8IOaIkOeGn+iwg+aVtCB8CnwgQU1QSyAgICAgICAgICAgfCA5MiAgICAgICAgICAgICAgIHwgMjAlICAgICAgICAgICAgICAgIHwg5qC45b+D5oiQ54afIHwKfCBTR0xUMiAgICAgICAgICB8IDk4ICAgICAgICAgICAgICAgfCAzMCUgICAgICAgICAgICAgICAgfCDmoLjlv4PmiJDnhp8gfAp8IEpBSzEgICAgICAgICAgIHwgMTEyICAgICAgICAgICAgICB8IDQwJSAgICAgICAgICAgICAgICB8IOaguOW/g+aIkOeGnyB8CnwgR0xQLTFSICAgICAgICAgfCAxMzggICAgICAgICAgICAgIHwgLTEwJSAgICAgICAgICAgICAgIHwg5qC45b+D5oiQ54afIHwKfCBUT1AxICAgICAgICAgICB8IDE0NSAgICAgICAgICAgICAgfCAyMCUgICAgICAgICAgICAgICAgfCDmoLjlv4PmiJDnhp8gfAp8IENPWCAgICAgICAgICAgIHwgMTUyICAgICAgICAgICAgICB8IC0zMCUgICAgICAgICAgICAgICB8IOaIkOeGn+iwg+aVtCB8CgoKIyMjIOi1hOaWmeadpea6kCAgCuWbvuihqOadpea6kO+8muOAijIwMjXlubTkuK3lm73kuLTluoror5Xpqozng63pl6jpnbbngrnnq57kuonmoLzlsYDjgIvvvIjms6jvvJrmsJTms6HlpKflsI/ku6PooajnlLPlip7kvIHkuJrmlbDvvIk=
收藏
竞争格局
2026-04-27
原图定位
查看详情
2025年中国临床试验各药品类型登记量占比
fCDoja/lk4HnsbvlnosgICAgICAgICB8IOeZu+iusOmHjyB8IOWNoOavlCAgIHwKfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwKfCDljJblraboja/niakgICAgICAgICB8IDM4ODMgICB8IDc0LjUlICB8Cnwg55Sf54mp5Yi25ZOBICAgICAgICAgfCAxMjA3ICAgfCAyMy4yJSAgfAp8IOS4reiNry/lpKnnhLboja/niakgICAgfCAxMjAgICAgfCAyLjMlICAgfAoK6LWE5paZ5p2l5rqQ77ya5pGp5qC55ZKo6K+i
收藏
行业数据
2026-04-27
原图定位
查看详情
2025年中国临床试验登记量TOP10品种
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
收藏
行业数据
2026-04-27
原图定位
查看详情
2025年中国临床试验热门治疗领域登记数量
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
收藏
行业数据
2026-04-27
原图定位
查看详情
2025年中国临床试验申办方TOP20
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
收藏
行业数据
2026-04-27
原图定位
查看详情
2025年新药临床试验登记量TOP10品种
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
收藏
行业数据
2026-04-27
原图定位
查看详情
2025年内外资临床试验登记数量占比
fCDnsbvliKsgfCDljaDmr5QgICB8CnwgLS0tLSB8IC0tLS0tLSB8Cnwg5YaF6LWEIHwgOTMuNCUgIHwKfCDlpJbotYQgfCA2LjYlICAgfAoK6LWE5paZ5p2l5rqQ77ya5pGp54a15ZKo6K+i
收藏
行业数据
2026-04-27
原图定位
查看详情
2021-2025年中国临床试验登记数量
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
收藏
行业数据
2026-04-27
原图定位
查看详情
2025年中国临床试验登记数量
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
收藏
行业数据
2026-04-27
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
目前,盐酸吉卡昔替尼片治疗重度斑秃适应症的 NDA 申请已经获得国家药品监督管理局受理。同时,盐酸吉卡昔替尼片目前正在开展多个其它免疫炎症性疾病的关键临床研究,包括用于中重度特应性皮炎(III 期)、强直性脊柱炎(III 期)等。此外,吉卡昔替尼片用于治疗 12岁及以上青少年和成人非节段型白癜风患者的 II/III 期临床试验已获得批准。 除片剂外,吉卡昔替尼还有乳膏剂型,目前正在开展轻中度斑秃、轻中度特应性皮炎、白癜风等多项自免疾病临床试验。
行业数据
原图定位
当前图表所属:
泽璟制药(688266)-A股公司研究报告:兼具销售放量和研发成果兑现的优秀创新药企-250731(20页).pdf
公司其他部分在研管线(截至20250720)
已开展NSCLC相关适应症的靶向TIGIT的抗体药物研发进度(截至20250720)
ZG005和AK104在宫颈癌的数据对比(截至20250720)
重点商业化品种概览(截至2025年5月30日)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》